U.S. Markets close in 48 mins

Cardiovascular Systems Inc (CSII) Files 10-K for the Fiscal Year Ended on June 30, 2018

- By insider

Cardiovascular Systems Inc (CSII) files its latest 10-K with SEC for the fiscal year ended on June 30, 2018. Cardiovascular Systems Inc is a medical technology company developing solutions for vascular and coronary disease. It treats patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. Cardiovascular Systems Inc has a market cap of $1.28 billion; its shares were traded at around $38.48 with a P/E ratio of 769.60 and P/S ratio of 6.04.


For the last quarter Cardiovascular Systems Inc reported a revenue of $59.2 million, compared with the revenue of $52.92 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $217.0 million, an increase of 5.9% from last year. For the last five years Cardiovascular Systems Inc had an average revenue growth rate of 15% a year.

The reported diluted earnings per share was 5 cents for the year, compared with the loss per share of $1.25 in the previous year. The Cardiovascular Systems Inc had an operating margin of 1.03%, compared with the operating margin of -0.75% a year before. The 10-year historical median operating margin of Cardiovascular Systems Inc is -21.58%. The profitability rank of the company is 6 (out of 10).

At the end of the fiscal year, Cardiovascular Systems Inc has the cash and cash equivalents of $116.3 million, compared with $107.9 million in the previous year. The long term debt was $21.1 million, compared with $21.1 million in the previous year. The interest coverage to the debt is 3, which is not a favorable level. Cardiovascular Systems Inc has a financial strength rank of 7 (out of 10).

At the current stock price of $38.48, Cardiovascular Systems Inc is traded at 97.7% premium to its historical median P/S valuation band of $19.46. The P/S ratio of the stock is 6.04, while the historical median P/S ratio is 3.06. The stock gained 29.07% during the past 12 months.

CFO Recent Trades:

  • CFO Jeffrey S. Points sold 971 shares of CSII stock on 08/17/2018 at the average price of $37.54. The price of the stock has increased by 2.5% since.

Directors and Officers Recent Trades:

  • General Counsel & Corp. Secy Alexander Rosenstein sold 1,344 shares of CSII stock on 08/17/2018 at the average price of $37.56. The price of the stock has increased by 2.45% since.
  • Chief Talent Officer Laura Gillund sold 2,147 shares of CSII stock on 08/17/2018 at the average price of $37.56. The price of the stock has increased by 2.45% since.
  • Chief Compliance Officer Sandra Sedo sold 862 shares of CSII stock on 08/17/2018 at the average price of $37.52. The price of the stock has increased by 2.56% since.

For the complete 20-year historical financial data of CSII, click here.

This article first appeared on GuruFocus.